SLP Nova

SLP Nova is a mobile application for speech-language pathologists (SLPs), as described by its author. The product is presented as a session companion that supports goal review, session recording, game trial capture, and AI-assisted support. It was built as part of the OpenAI 2026 hackathon.

The description provides no evidence of revenue, customers, or traction. The project appears to be early-stage, self-reported, and unverified. The single most important open question is whether SLP Nova has any real-world adoption or usage by SLPs — this cannot be determined from the provided information.

The description states that SLP Nova is a mobile session companion for speech-language pathologists (SLPs). It supports:

• Reviewing goals
• Recording sessions
• Capturing goal-linked game trials
• Using AI support
• Turning every session into clinician-reviewed evidence

It was built using technologies including Azure services, Expo Router, React Native, Next.js, OpenAI Codex, PostgreSQL, Supabase Auth, and TypeScript.

Evidence: The author describes the product as a mobile app for SLPs with specific features. No screenshots, demos, or functional details are provided.

Inference: Based on the tech stack and feature claims, it appears to be a mobile-native application built for clinical use in speech therapy settings.

The author positions SLP Nova as a mobile session companion that integrates AI support into speech-language pathology workflows. It is described as enabling clinicians to review goals, record sessions, capture game trials, and generate evidence-based documentation.

There is no indication of prior positioning or evolution in claims — this is the first public statement about the product.

Evidence: The tagline and self-description are the only claims made by the author.

Inference: The positioning suggests a tool for improving documentation and AI-assisted support in clinical speech therapy, but there is no evidence of market validation or prior versions.

The description states that SLP Nova is intended for speech-language pathologists (SLPs). It is designed to support their session review, recording, and goal-linked game trial capture.

No further segmentation or identification of specific customer types within the SLP community is provided.

Evidence: The author identifies SLPs as the target user group.

Inference: The ICP appears to be clinicians working in speech therapy, but no evidence exists regarding their adoption, needs, or feedback.

There is no evidence of a business model or pricing structure. The description does not mention monetization, subscriptions, licensing, or any commercial arrangements.

Evidence: Not evidenced.

Inference: If the product is commercialized, it would likely be sold to clinics or SLPs, but no such details are provided.

The project was built using:

• Frontend: React Native (via Expo), Next.js
• Backend: Azure services (App Service, Blob Storage, Key Vault), PostgreSQL, Supabase Auth
• AI Tools: OpenAI Codex, GPT-5.6 (as per author-declared tech stack)
• CI/CD: GitHub Actions

The project was submitted to the OpenAI 2026 hackathon.

Evidence: The author lists the technologies used in development.

Inference: The use of React Native and Expo suggests a mobile-first approach, while Azure services imply cloud infrastructure. The inclusion of AI tools suggests integration with generative AI capabilities.

There is no evidence of traction or maturity. The project was submitted to a hackathon, and no customer base, usage metrics, or product adoption are mentioned.

Evidence: Not evidenced.

Inference: The project is likely early-stage, possibly pre-product-market fit, with no indication of real-world use or user feedback.

There is no evidence of competitive analysis or market positioning against existing tools. No mention of competitors, similar products, or market gaps addressed.

Evidence: Not evidenced.

Inference: SLPs may use other tools for session recording and documentation, but no information is provided about the competitive landscape.

• No traction or adoption evidence: The product is presented as a hackathon submission with no real-world usage.
• Unverified claims: All features and functionality are self-reported.
• Unclear commercial viability: No pricing, monetization, or business model described.
• Limited team size: Only one team member (Sebastian GM) is mentioned.
• AI integration uncertainty: GPT-5.6 is listed as a tech stack element, but no clarity on how it's used or integrated.

Evidence: Not evidenced.

Inference: The lack of evidence for any commercial or user traction raises significant concerns about product viability and market readiness.

1. What specific clinical workflows does SLP Nova aim to improve?
2. How is the AI support integrated into session documentation?
3. Have you tested the app with actual SLPs or clinics?
4. Is there a plan for monetization or commercial deployment?
5. What are the key challenges in building and deploying this tool in clinical environments?